246 filings
Page 4 of 13
DEF 14C
3spvsj9 st4jcqs
25 Jul 22
Information statement
7:00am
8-K/A
ffbefldsjtjuiysfdy
18 Jul 22
Entry into a Material Definitive Agreement
5:10pm
PRE 14C
o4xh14ch5q4vd8sa1rr
15 Jul 22
Preliminary information
5:12pm
8-K
zp75esiw9g 2t4uibek9
15 Jul 22
Entry into a Material Definitive Agreement
5:10pm
8-K
fs78d3bo0
29 Jun 22
Developing Transformative Therapies to Overcome Chronic Debilitating Diseases Corporate Presentation • June 2022
8:29am
8-K
858v70bns sbx
1 Dec 21
Entry into a Material Definitive Agreement
9:15am
8-K
tgy5su8tx6i dgmk
14 Oct 21
Submission of Matters to a Vote of Security Holders
8:02am
S-8
nd426eqk8fudkq
4 Oct 21
Registration of securities for employees
4:41pm
8-K
nlqgk 90dl
11 Aug 21
BioVie Inc. Announces Pricing of Public Offering of Common Stock
1:23pm
424B5
gl99q6
10 Aug 21
Prospectus supplement for primary offering
12:00am
FWP
dhqikwgf 4sg
6 Aug 21
Free writing prospectus
5:22pm
424B5
xajt2n
6 Aug 21
Prospectus supplement for primary offering
5:21pm
8-K
ahfruli4j8ih mk
5 Aug 21
BioVie Announces First Patient Enrolled in Phase 3 Study of NE3107 in Alzheimer’s Disease
4:25pm
8-K
boijqr85ec27ae5w
11 Jun 21
BioVie Announces Closing of Acquisition of BioPharma Assets from Privately Held NeurMedix
9:00am
DEFM14C
intqldilhfck
20 May 21
Information related to merger
4:47pm